Aung Myo | Vice President, Clinical Development
Tessa Therapeutics | Singapore

Aung Myo, Vice President, Clinical Development, Tessa Therapeutics

•    A medical oncologist, with a broad and deep range of experience in pharmaceutical industry for both clinical development and medical affairs in oncology area. Lead regional team of clinical and medical affairs for cancer immunotherapy working with 14 countries across Asia Pacific
•    A regional leader for clinical development of Cancer Immunotherapy trials, ranging from tumor maker studies to various phases of clinical trials and investigator-sponsored studies in Asia Pacific. Experienced in global clinical development as the leader for Esophageal,Gastric cancers and HCC. Involved in IND application, safety and compliance
•    A leader of regional medical affairs for Oncology medical affairs who set up and lead Oncology Medical Affairs Organization in Asia Pacific, and formulate medical affairs strategies and action plans for Anti-PD1 immunotherapy. Lead “new product introduction” team (commercial, regulatory, market access teams) for launch preparation, and provide medical support for launch and post-launch activities.Organise regional advisory boards and medical educational activities and has peer-to-peer relationship with oncology experts in the region
•    A good track record of scientific oncology publications and a speaker at Asia-Pacific conferences
•    Specialty: 
•    Clinical development
•    Medical affairs
•    Cancer Immunotherapy
•    Oncology
•    Asia Pacific
•    New product introduction
•    Medical monitor and advisor
•    Building and leading of regional Clinical and medical affairs team
•    Executive management and leadership
•    Scientific publication
•    Conference speaker
•    Medical oncologist


Phar-East Day 1 @ 11:20

What’s next after PD-L1?

last published: 19/Feb/19 03:35 GMT

back to speakers






For speaking, sponsorship and exhibition opportunities contact
Tel: +65 6322 2738